With this prospective, observational study, we would like to investigate the effect of instillation therapy using BCG or mitomycin C on short- and long-term irritative and obstructive lower urinary tract symptoms using validated questionnaires. The study will objectify the lower urinary tract symptoms and thereby provide better recommendations for therapy with mitomycin C or BCG.
Study Type
OBSERVATIONAL
Enrollment
60
BPIC-SS, ICIQ-OABqol, IIEF-EF oder FSFI, ICIQ-MLUTS oder ICIQ-FLUTS
Nikolaos Pyrgidis
Munich, Bavaria, Germany
RECRUITINGEffect of instillation therapy on quality of life
Quality of life will be measured with validated questionnaires such as the ICIQ-OABqol
Time frame: During the study period approximately 12 months
Effect of instillation therapy on sexuality
Sexuality will be measured with validated questionnaires such as the IIEF-EF (men) and the FSFI (women)
Time frame: During the study period approximately 12 months
Effect of instillation therapy on lower urinary tract symptoms
Lower urinary tract symptoms will be measured with validated questionnaires such as the BPIC-SS, the ICIQ-MLUTS (men) and the ICIQ-FLUTS (women)
Time frame: During the study period approximately 12 months
Complications during instillation therapy
The frequency of all complications will be measured and will be subsequently classified based on the Clavien-Dindo classification
Time frame: During the study period approximately 12 months
Discontinuation rate of instillation therapy
Time frame: During the study period approximately 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.